BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29878346)

  • 1. Nicotinic acetylcholine receptors.
    Wonnacott S; Bermudez I; Millar NS; Tzartos SJ
    Br J Pharmacol; 2018 Jun; 175(11):1785-1788. PubMed ID: 29878346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
    Wang J; Lindstrom J
    Br J Pharmacol; 2018 Jun; 175(11):1805-1821. PubMed ID: 28199738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptors at the single-channel level.
    Bouzat C; Sine SM
    Br J Pharmacol; 2018 Jun; 175(11):1789-1804. PubMed ID: 28261794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.
    Cuny H; Yu R; Tae HS; Kompella SN; Adams DJ
    Br J Pharmacol; 2018 Jun; 175(11):1855-1868. PubMed ID: 28477355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.
    Crespi A; Colombo SF; Gotti C
    Br J Pharmacol; 2018 Jun; 175(11):1869-1879. PubMed ID: 28294298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-induced regulation of ligand-gated channel activity.
    Bregestovski P; Maleeva G; Gorostiza P
    Br J Pharmacol; 2018 Jun; 175(11):1892-1902. PubMed ID: 28859250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding structure-function relationships of the human neuronal acetylcholine receptor: insights from the first crystal structures of neuronal subunits.
    Giastas P; Zouridakis M; Tzartos SJ
    Br J Pharmacol; 2018 Jun; 175(11):1880-1891. PubMed ID: 28452148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging areas of opioid pharmacology.
    Kelly E; Henderson G; Bailey CP
    Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fifth subunit of the (α4β2)
    New K; Del Villar SG; Mazzaferro S; Alcaino C; Bermudez I
    Br J Pharmacol; 2018 Jun; 175(11):1822-1837. PubMed ID: 28600847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α9-containing nicotinic acetylcholine receptors and the modulation of pain.
    Hone AJ; Servent D; McIntosh JM
    Br J Pharmacol; 2018 Jun; 175(11):1915-1927. PubMed ID: 28662295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human secreted proteins SLURP-1 and SLURP-2 control the growth of epithelial cancer cells via interactions with nicotinic acetylcholine receptors.
    Lyukmanova EN; Bychkov ML; Sharonov GV; Efremenko AV; Shulepko MA; Kulbatskii DS; Shenkarev ZO; Feofanov AV; Dolgikh DA; Kirpichnikov MP
    Br J Pharmacol; 2018 Jun; 175(11):1973-1986. PubMed ID: 29505672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
    Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
    Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced α4 subunit expression in α4
    Moretti M; Fasoli F; Gotti C; Marks MJ
    Br J Pharmacol; 2018 Jun; 175(11):1944-1956. PubMed ID: 28585241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loops D, E and G in the Drosophila Dα1 subunit contribute to high neonicotinoid sensitivity of Dα1-chicken β2 nicotinic acetylcholine receptor.
    Ihara M; Hikida M; Matsushita H; Yamanaka K; Kishimoto Y; Kubo K; Watanabe S; Sakamoto M; Matsui K; Yamaguchi A; Okuhara D; Furutani S; Sattelle DB; Matsuda K
    Br J Pharmacol; 2018 Jun; 175(11):1999-2012. PubMed ID: 28616862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonicotinoid insecticides differently modulate acetycholine-induced currents on mammalian α7 nicotinic acetylcholine receptors.
    Cartereau A; Martin C; Thany SH
    Br J Pharmacol; 2018 Jun; 175(11):1987-1998. PubMed ID: 28853147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pharmacology of G protein-coupled receptors.
    Summers RJ
    Br J Pharmacol; 2016 Oct; 173(20):2931-3. PubMed ID: 27682321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of nicotinic acetylcholine receptors.
    Chatzidaki A; Millar NS
    Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.
    Papke RL; Stokes C; Damaj MI; Thakur GA; Manther K; Treinin M; Bagdas D; Kulkarni AR; Horenstein NA
    Br J Pharmacol; 2018 Jun; 175(11):1838-1854. PubMed ID: 28477386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pharmacology of GPCRs.
    Langmead CJ; Summers RJ
    Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting inflammation to reduce cardiovascular disease risk.
    Maffia P; Cirino G
    Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.